top of page

BackTable / VI / Podcast / Episode #475

Bariatric Embolization for Obesity Management

with Dr. Clifford Weiss

While GLP-1 agonists continue to gain popularity in the medical management of diabetes and obesity, Dr. Cliff Weiss is exploring bariatric arterial embolization (BAE) as an adjunctive therapy to help patients sustain weight loss. Dr. Weiss, the Director of IR Research at Johns Hopkins, joins the show to discuss the techniques and impacts of BAE for obesity treatment.

This podcast is supported by:

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Bariatric Embolization for Obesity Management with Dr. Clifford Weiss on the BackTable VI Podcast
Ep 475 Bariatric Embolization for Obesity Management with Dr. Clifford Weiss
00:00 / 01:04

BackTable, LLC (Producer). (2024, August 20). Ep. 475 – Bariatric Embolization for Obesity Management [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcast Contributors

Dr. Michael Barraza on the BackTable VI Podcast

Dr. Michael Barraza is a practicing interventional radiologist (and all around great guy) with Radiology Associates in Baton Rouge, LA.

Dr. Clifford Weiss on the BackTable VI Podcast

Dr. Clifford Weiss is a interventional radiologist at Johns Hopkins Hospital in Baltimore, Maryland.

Synopsis

Dr. Weiss outlines his initial research interest in gastric embolization of the fundus to reduce ghrelin production. He began by studying the use of sclerosants for embolization but later shifted to using embolic spheres. BAE involves the targeted embolization of the left gastric artery, with or without the left gastroepiploic artery, using 300-500 micron embolic spheres. Dr. Weiss also employs a dilute mixture of spheres and a vasodilator to achieve distal arterial penetration.

He describes the role of BAE in conjunction with existing surgical and pharmaceutical treatments. According to his experience, patients undergoing BAE achieve maximum weight loss 6-9 months after the procedure and can maintain this weight when they follow up in a weight management clinic. Additionally, Dr. Weiss reviews data from BAE studies, including the BEAT Obesity Trial and the recent BEATLES Trial.

Timestamps

00:00 - Introduction
03:21 - Early Research and Development of BAE
07:39 - Potential Role of BAE in Obesity Treatment
16:03 - Procedure Details
25:28 - Post-Procedure Care and Patient Management
28:06 - Insights from the BEAT Obesity Trial
33:38 - BEATLES Trial
37:38 - Combination Therapy for Obesity

Resources

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

backtable-plus-vi-cta.jpg
Become a BackTable Sponsor

Up Next

Resorbable Embolics in MSK Embolizations with Dr. Keerthi Prasad on the BackTable VI Podcast
Frontiers in Musculoskeletal Embolization  with Dr. Yuji Okuno on the BackTable VI Podcast
¿Es la Embolización el Futuro? Hablemos de Emborrhoid con Dr. José Andrés Guirola Ortíz on the BackTable VI Podcast
Tackling Upper GI Bleeds: Techniques & Tools with Dr. Osman Ahmed on the BackTable VI Podcast
Emergent Cases: The Impact of Arterial Sheath Technology with Dr. Rehan Quadri on the BackTable VI Podcast
Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and Deondra Bonds-Adams on the BackTable VI Podcast

Articles

Topics

Bariatric Arterial Embolization (BAE) Podcasts
Obesity Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.

bottom of page